...
首页> 外文期刊>Oncology Research >miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2
【24h】

miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2

机译:miR-615通过直接靶向细胞周期蛋白D2抑制前列腺癌细胞增殖和侵袭

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies have reported that miR-615 exerts a tumor suppressor role in some tumors, such as esophageal squamous cell carcinoma and non-small cell lung cancer. However, the role of miR-615 in prostate cancer has not been defined. Here we found that miR-615 was downregulated in prostate cancer tissues and cell lines. Overexpression of miR-615 in PC-3 cells significantly inhibited cellular proliferation, migration, and invasion. Moreover, overexpression of miR-615 delayed tumor growth in vivo. In tenns of mechanism, we found that cyclin D2 (CCND2) is a target gene of miR-615 in prostate cancer. We showed that miR-615 could bind to the 3 -UTR region of CCND2 mRNA and inhibit its expression. There was a negative correlation between the expression of miR-615 and CCND2 in prostate cancer tissues. Moreover, restoration of cyclin D2 abolished the inhibitory effects of miR-615 on the proliferation, migration, and invasion of prostate cancer cells. Taken together, our study identified miR-615 as a tumor suppressor by targeting cyclin D2 in prostate cancer.
机译:以前的研究报道,MIR-615在一些肿瘤中施加肿瘤抑制作用,例如食道鳞状细胞癌和非小细胞肺癌。然而,未定义miR-615在前列腺癌中的作用。在这里,我们发现miR-615在前列腺癌组织和细胞系中下调。 PC-3细胞中miR-615的过度表达显着抑制细胞增殖,迁移和侵袭。此外,MIR-615的过表达延迟了体内肿瘤生长。在机制的Tenns中,我们发现细胞周期蛋白D2(CCND2)是前列腺癌中miR-615的靶基因。我们表明miR-615可以结合CCND2 mRNA的3-rr区域并抑制其表达。 miR-615和CCND2在前列腺癌组织中的表达之间存在负相关性。此外,细胞周期蛋白D2的恢复废除了miR-615对前列腺癌细胞的增殖,迁移和侵袭的抑制作用。通过靶向前列腺癌中的细胞周期蛋白D2,我们的研究将我们的研究确定为肿瘤抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号